GO:0032310 prostaglandin secretion: Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032310 prostaglandin secretion is the regulated release of prostaglandins, a group of cyclopentane-ring-containing bioactive metabolites, from a cell or tissue.
• Prostaglandin secretion is a biological process that can occur in diverse tissues, including adrenal tissue of human anencephalic fetuses.
• Prostaglandins such as PGE1 and PGD2 modulate secretion and permeability in the gastrointestinal tract, including acid secretion and mucus secretion.
• Dysregulated prostaglandin secretion is linked to chronic watery diarrhea and other gastrointestinal disorders.
• Key genes involved include prostaglandin synthases (PTGS1, PTGS2), terminal synthases (PTGES, PTGDS, PTGIS), and transporters such as ABCC4 and SLCO2A1.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of prostaglandin secretion pathways in human cells.
Description
Prostaglandin secretion (GO:0032310) is defined as the regulated release of a prostaglandin, any of a group of biologically active metabolites which contain a cyclopentane ring, from a cell or a tissue. Prostaglandins are locally acting lipid mediators that influence diverse physiological processes, including gastrointestinal secretion, vascular tone, and inflammation. The process of secretion is distinct from prostaglandin synthesis and involves specific transporters and signaling events that export these molecules to the extracellular space. Understanding prostaglandin secretion is important because it represents a control point for prostaglandin bioavailability and downstream signaling. In the gastrointestinal tract, prostaglandins such as PGE1 and PGD2 regulate acid secretion and mucosal barrier function, and their secretion is implicated in diarrheal diseases. In reproductive and endocrine tissues, prostaglandin secretion by adrenal tissue of human anencephalic fetuses has been documented, highlighting its role in development and endocrine physiology. Thus, GO:0032310 encompasses a fundamental cellular export process with broad physiological and pathological relevance.
prostaglandin secretion At A Glance
| GO ID | GO:0032310 |
|---|---|
| GO term | prostaglandin secretion |
| Ontology | biological_process |
| Synonym | prostacyclin secretion |
| Definition | The regulated release of a prostaglandin, any of a group of biologically active metabolites which contain a cyclopentane ring, from a cell or a tissue. |
| Major function | Export of prostaglandins to the extracellular space for autocrine and paracrine signaling |
| Related processes | Prostaglandin biosynthesis, transport, and signaling |
| Tissue examples | Adrenal tissue, gastrointestinal mucosa, vascular endothelium |
| Disease relevance | Chronic watery diarrhea, gastrointestinal disorders, inflammation |
What Is GO:0032310?
In our own words, GO:0032310 prostaglandin secretion describes the controlled export of prostaglandin molecules from a cell or tissue into the surrounding environment. Prostaglandins are a family of bioactive lipids characterized by a cyclopentane ring. This process is not merely passive diffusion; it is a regulated release that can be stimulated or inhibited by physiological signals. The synonym prostacyclin secretion reflects that prostacyclin (PGI2) is one member of the prostaglandin family whose release is covered by this term. The term is a biological process and is distinct from prostaglandin biosynthetic processes, although secretion depends on prior synthesis.
Why Is prostaglandin secretion Important in Cell Biology?
Prostaglandin secretion is critically important because it determines the availability of prostaglandins at their sites of action, thereby influencing a wide range of physiological and pathological processes. Prostaglandins regulate gastric acid secretion, mucosal protection, intestinal permeability, and smooth muscle contraction. Dysregulated secretion contributes to chronic watery diarrhea, a common and debilitating condition. In endocrine tissues, prostaglandin secretion by the adrenal gland of anencephalic fetuses suggests roles in fetal development and steroidogenesis. Moreover, prostaglandin secretion is a potential therapeutic target, as modulating secretion could alter disease outcomes in gastrointestinal and inflammatory conditions. Therefore, studying GO:0032310 provides insights into basic cell biology and offers translational opportunities.
• Regulates gastrointestinal acid secretion and mucosal defense.
• Modulates intestinal permeability and mucus secretion, impacting barrier function.
• Implicated in the pathophysiology of chronic watery diarrhea.
• Plays a role in endocrine tissues such as the adrenal gland during fetal development.
• Affects vascular tone and hemostasis through prostacyclin secretion.
• Serves as a control point for inflammatory mediator release.
• Provides targets for anti-diarrheal and anti-inflammatory therapies.
• Enables autocrine and paracrine signaling in diverse tissues.
• Can be studied using CRISPR-based genetic models to dissect gene function.
• Offers biomarkers for prostaglandin-related disorders.
What Happens During prostaglandin secretion?
Prostaglandin synthesis and substrate availability
In simple terms: First, cells make prostaglandins from arachidonic acid before they can secrete them.
Prostaglandin secretion depends on the prior synthesis of prostaglandins, which are derived from arachidonic acid via cyclooxygenase enzymes. The term GO:0032310 specifically covers the release step, but this step is functionally coupled to biosynthesis because only synthesized prostaglandins are available for export. In adrenal tissue of human anencephalic fetuses, prostaglandin secretion indicates active synthesis and release. Thus, the first stage of the process is the intracellular production of prostaglandins, which sets the stage for regulated secretion.
Intracellular transport to the plasma membrane
In simple terms: Prostaglandins must move from where they are made to the cell surface.
After synthesis, prostaglandins are transported within the cell to the plasma membrane for release. While the exact mechanisms are not fully detailed in the cited literature, the process is known to be regulated and can be influenced by cellular signals. In gastrointestinal epithelial cells, prostaglandin secretion is stimulated under specific conditions, suggesting active intracellular trafficking. This step ensures that prostaglandins are positioned for export.
Membrane export via transporters
In simple terms: Specialized proteins in the cell membrane pump prostaglandins out of the cell.
The regulated release of prostaglandins across the plasma membrane is mediated by specific transporters, although the exact molecular identities are not fully covered in the cited references. The process is described as regulated release, implying the involvement of protein-mediated transport. In the context of intestinal permeability, prostaglandin D2 signaling stimulates mucus secretion, which may involve prostaglandin release from cells. This export step is a key control point for prostaglandin bioavailability.
Extracellular signaling and feedback
In simple terms: Once outside, prostaglandins act on nearby cells and can influence further secretion.
Secreted prostaglandins act on G-protein-coupled receptors on target cells to elicit responses such as acid secretion inhibition or mucus secretion stimulation. For example, prostaglandin E1 affects acid secretion and histamine content in the rat stomach. Prostaglandin D2 enhances intestinal barrier function by stimulating mucus secretion. These extracellular actions can feed back to regulate further prostaglandin secretion, contributing to homeostatic control.
Key Genes Involved in GO:0032310 prostaglandin secretion
The following genes are involved in prostaglandin synthesis, transport, and signaling, and are relevant to studying GO:0032310 prostaglandin secretion.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PTGS1 | Cyclooxygenase-1, converts arachidonic acid to prostaglandin H2 | Constitutive prostaglandin synthesis; target for NSAIDs |
| PTGS2 | Cyclooxygenase-2, inducible isoform for prostaglandin synthesis | Inflammation and cancer; inducible secretion |
| PTGES | Microsomal prostaglandin E synthase, produces PGE2 | PGE2 secretion in inflammation and cancer |
| PTGDS | Prostaglandin D2 synthase, produces PGD2 | PGD2 secretion in allergy and intestinal barrier |
| PTGIS | Prostacyclin synthase, produces PGI2 | Prostacyclin secretion in vascular biology |
| TBXAS1 | Thromboxane A synthase, produces TXA2 | Thromboxane secretion in platelet function |
| ABCC4 | ATP-binding cassette transporter, exports prostaglandins | Prostaglandin efflux; drug resistance |
| SLCO2A1 | Prostaglandin transporter, mediates uptake and clearance | Prostaglandin transport and secretion balance |
| HPGD | 15-hydroxyprostaglandin dehydrogenase, degrades prostaglandins | Regulates prostaglandin half-life and secretion |
| PTGER1 | PGE2 receptor EP1 | Signaling downstream of secreted PGE2 |
| PTGER2 | PGE2 receptor EP2 | Signaling in inflammation and cancer |
| PTGER4 | PGE2 receptor EP4 | Signaling in immune modulation |
| PTGDR | PGD2 receptor DP1 | Mucus secretion and barrier function |
| PTGFR | PGF2α receptor | Uterine contraction and secretion |
| PPARG | Peroxisome proliferator-activated receptor gamma | Downstream of prostaglandins; metabolic regulation |
| NFKB1 | Nuclear factor kappa B, regulates PTGS2 expression | Inflammatory control of prostaglandin secretion |
| PLA2G4A | Phospholipase A2, releases arachidonic acid | Rate-limiting for prostaglandin synthesis and secretion |
How Is prostaglandin secretion Regulated?
Prostaglandin secretion is regulated at multiple levels. The availability of arachidonic acid, released by phospholipase A2, controls substrate supply for prostaglandin synthesis. Cyclooxygenase enzymes (PTGS1 and PTGS2) are differentially regulated, with PTGS2 being inducible by inflammatory stimuli. Transporters such as ABCC4 and SLCO2A1 modulate the efflux and reuptake of prostaglandins, thereby influencing net secretion. In the gastrointestinal tract, prostaglandin secretion can be stimulated by physiological signals, as shown by prostaglandin D2 enhancing mucus secretion. Additionally, prostaglandin E1 affects acid secretion and histamine content in the stomach, indicating feedback regulation. Thus, prostaglandin secretion is controlled by synthesis, transport, and receptor-mediated feedback.
prostaglandin secretion and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PTGS2 | Inflammation and cancer | Knockout and overexpression in intestinal epithelial cells |
| PTGDS | Intestinal barrier dysfunction | Knockout in Caco-2 cells to assess mucus secretion |
| ABCC4 | Prostaglandin efflux and drug resistance | Knockout in HeLa or HEK293 cells for transport assays |
| SLCO2A1 | Prostaglandin clearance disorders | Point mutation knock-in to mimic patient variants |
| HPGD | Prostaglandin degradation defects | Knockout in macrophages to measure prostaglandin levels |
Chronic Watery Diarrhea
Chronic watery diarrhea is a common condition with diverse etiologies, and prostaglandins are known to influence intestinal secretion and motility. Prostaglandin D2 signaling enhances intestinal barrier function by stimulating mucus secretion, suggesting that impaired prostaglandin secretion could contribute to barrier dysfunction and diarrhea. Prostaglandin E1 affects acid secretion and mucosal histamine, which may impact gut homeostasis. Therefore, dysregulated prostaglandin secretion is implicated in the pathophysiology of chronic watery diarrhea.
Gastrointestinal Ulcer Disease
Prostaglandins play a protective role in the gastric mucosa by inhibiting acid secretion and promoting mucus and bicarbonate secretion. Prostaglandin E1 has been shown to affect acid secretion, mucosal histamine content, and histidine decarboxylase activity in the rat stomach. Impaired prostaglandin secretion could therefore contribute to ulcer formation. Understanding the secretion process may inform therapies for peptic ulcer disease.
Inflammatory Disorders
Prostaglandins are key mediators of inflammation, and their secretion is increased in inflammatory conditions. Prostaglandin E2 and prostacyclin are among the most abundant prostaglandins at sites of inflammation. Secretion of these mediators amplifies vascular permeability and immune cell recruitment. Targeting prostaglandin secretion pathways could offer anti-inflammatory strategies.
From prostaglandin secretion-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does PTGS2 knockout reduce prostaglandin secretion? | CRISPR knockout in human cell lines (e.g., HEK293, Caco-2) |
| Does a specific point mutation in ABCC4 alter transport activity? | CRISPR point mutation knock-in in HEK293 cells |
| Can we tag endogenous PTGDS to track secretion? | Knock-in of fluorescent tag at PTGDS locus |
| Does overexpression of PTGES increase PGE2 secretion? | CRISPR overexpression (e.g., CRISPRa) in A549 cells |
| Which genes regulate prostaglandin secretion in a genome-wide manner? | CRISPR library screening in a secretion reporter cell line |
| Does SLCO2A1 deficiency affect prostaglandin reuptake? | Knockout in primary endothelial cells |
How to Study the prostaglandin secretion Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ELISA | Concentration of specific prostaglandins in medium | Quantify PGE2 or PGD2 secretion from cells |
| Mass spectrometry | Prostaglandin profiles and quantities | Comprehensive lipidomics of secreted prostaglandins |
| CRISPR knockout | Loss-of-function effects on secretion | Test candidate gene necessity |
| CRISPR point mutation | Effect of specific amino acid changes | Model patient variants in transporters |
| CRISPR knock-in | Tagged protein localization and secretion | Track endogenous prostaglandin synthase |
| CRISPR overexpression | Gain-of-function effects on secretion | Assess sufficiency of a gene |
| RNA-seq | Transcriptional changes associated with secretion | Identify co-regulated genes |
| Proteomics | Protein abundance and modifications | Discover novel secretion regulators |
Quantifying Prostaglandin Secretion
Prostaglandin secretion can be measured by collecting conditioned medium from cultured cells and quantifying prostaglandin levels using enzyme-linked immunosorbent assay (ELISA) or mass spectrometry. These methods allow researchers to assess the release of specific prostaglandins such as PGE2 or PGD2 under different conditions. In tissue explants, secretion can be measured similarly.
Genetic Manipulation with CRISPR
CRISPR-Cas9 genome editing enables knockout, point mutation, knock-in, and overexpression of genes involved in prostaglandin secretion. By disrupting candidate genes such as PTGS2 or ABCC4, researchers can determine their causal role in secretion. These approaches are essential for dissecting the molecular machinery of GO:0032310.
Transcriptomic and Proteomic Profiling
RNA sequencing and proteomics can identify genes and proteins that are co-regulated with prostaglandin secretion. For example, stimulation of mucus secretion by PGD2 may involve transcriptional changes. Such profiling can reveal novel regulators of prostaglandin secretion.
Imaging and Live-Cell Assays
Fluorescent reporters or tagged prostaglandin-binding proteins can be used to visualize secretion in live cells. While specific reporters are not detailed in the cited literature, imaging approaches can complement biochemical assays. These methods provide spatial and temporal resolution of the secretion process.
How CRISPR Can Be Used to Study GO:0032310 prostaglandin secretion
Knockout
CRISPR knockout of genes such as PTGS2, PTGES, or ABCC4 can abolish or reduce prostaglandin secretion, allowing researchers to test necessity. For example, knocking out PTGS2 in human cells would eliminate inducible prostaglandin synthesis and thus secretion. Knockout models are foundational for assigning function to candidate genes in GO:0032310.
Point Mutation
Point mutations can be introduced into genes encoding transporters or enzymes to model patient-specific variants or to dissect catalytic residues. For instance, mutating the ATP-binding domain of ABCC4 could impair prostaglandin efflux without affecting protein stability. Such models provide mechanistic insights into secretion defects.
Knock-in
Knock-in of tags (e.g., GFP, HA) at endogenous loci enables real-time tracking of prostaglandin synthases or transporters. This approach preserves native regulation and can reveal dynamic changes during secretion. Knock-in models are valuable for studying trafficking and localization.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can increase the levels of genes like PTGES or PTGIS to test sufficiency for enhanced secretion. Overexpression models help identify rate-limiting steps and potential therapeutic targets. They complement loss-of-function studies.
How EDITGENE Supports prostaglandin secretion Research
Researchers studying prostaglandin secretion-related genes often need to determine whether a candidate gene is causally involved in the regulated release of prostaglandins. EDITGENE provides comprehensive CRISPR-based services to enable such causal studies in relevant human cell models.
Contact EDITGENE today to design your custom CRISPR model for prostaglandin secretion research.
Frequently Asked Questions About prostaglandin secretion
What is prostaglandin secretion?
Prostaglandin secretion (GO:0032310) is the regulated release of prostaglandins, a group of bioactive metabolites containing a cyclopentane ring, from a cell or tissue.
What genes are involved in prostaglandin secretion?
Key genes include PTGS1, PTGS2, PTGES, PTGDS, PTGIS, ABCC4, SLCO2A1, and HPGD, among others.
How is prostaglandin secretion measured?
It is typically measured by ELISA or mass spectrometry of conditioned medium from cells or tissues.
What is the role of prostaglandin secretion in diarrhea?
Prostaglandins influence intestinal secretion and barrier function; dysregulated secretion is implicated in chronic watery diarrhea.
Can CRISPR be used to study prostaglandin secretion?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable causal studies of genes involved in prostaglandin secretion.
What is the synonym for GO:0032310?
The synonym is prostacyclin secretion.
Which tissues secrete prostaglandins?
Prostaglandin secretion occurs in diverse tissues, including adrenal tissue, gastrointestinal mucosa, and vascular endothelium.
How does prostaglandin E1 affect gastric secretion?
Prostaglandin E1 affects acid secretion, mucosal histamine content, and histidine decarboxylase activity in the rat stomach.
Does prostaglandin D2 affect intestinal permeability?
Yes, enhancement of prostaglandin D2 signaling reduces intestinal permeability by stimulating mucus secretion.
What are the research methods for prostaglandin secretion?
Common methods include ELISA, mass spectrometry, CRISPR genome editing, RNA-seq, and proteomics.
Conclusion
GO:0032310 prostaglandin secretion is a fundamental biological process that controls the extracellular availability of prostaglandins, which are key regulators of gastrointestinal, vascular, and inflammatory functions. Dysregulation of this process is linked to chronic watery diarrhea and other disorders. Advances in CRISPR genome editing now allow precise interrogation of the genes and pathways that govern prostaglandin secretion. By combining loss-of-function, gain-of-function, and tagging approaches, researchers can uncover novel therapeutic targets. EDITGENE provides the tools and expertise to accelerate such discoveries.
References
- 1. Camilleri M et al.. 2017. Pathophysiology, Evaluation, and Management of Chronic Watery Diarrhea.. Gastroenterology 152(3):515-532.e2 PMID: 27773805
- 2. Unknown. 1969. Prostaglandins.. Can Med Assoc J 100(1):37-8 PMID: 4303212
- 3. Carr BR et al.. 1986. Prostaglandin secretion by adrenal tissue of human anencephalic fetuses.. Am J Obstet Gynecol 154(2):373-8 PMID: 3456203
- 5. Fülgraff G. 1973. [Prostaglandins].. Med Klin 68(7):195-201 PMID: 4633865
- 6. Wada T et al.. 1970. [Effects of prostaglandin on the function of the gastric secretion].. Nihon Rinsho 28(10):2465-8 PMID: 4920007
- 7. Hayashi A et al.. 2023. Enhancement of prostaglandin D(2)-D prostanoid 1 signaling reduces intestinal permeability by stimulating mucus secretion.. Front Immunol 14:1276852 PMID: 37942331
- 8. Håkanson R et al.. 1973. Effects of prostaglandin E1 on acid secretion, mucosal histamine content and histidine decarboxylase activity in rat stomach.. Br J Pharmacol 47(3):498-503 PMID: 4730828
